Ignite Creation Date:
2025-12-25 @ 1:39 AM
Ignite Modification Date:
2026-01-03 @ 5:26 PM
Study NCT ID:
NCT01478594
Status:
COMPLETED
Last Update Posted:
2015-07-08
First Post:
2011-11-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study Combining mFOLFOX6 With Tivozanib or Bevacizumab in Patients With Metastatic Colorectal Cancer as First Line Therapy
Sponsor:
AVEO Pharmaceuticals, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Colorectal Cancer | View |